Inspire Medical Systems Analyst Price Targets

Wall Street analyst price targets and consensus rating for Inspire Medical Systems (INSP).

Price Target Range — 9 Quarters

Analyst Consensus — 15 Analysts

6Buy

8Hold

1Sell

Consensus RatingBuy# Analysts15Avg. Consensus PT$83Upside to Avg. PT+32.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 4, 2026	JP Morgan	Robbie Marcus	PT Raise	Neutral	$54→$60
Aug 4, 2026	Mizuho	Anthony Petrone	PT Raise	Outperform	$55→$65
Aug 4, 2026	Oppenheimer	Suraj Kalia	Upgrade	Perform→Outperform	$85
Aug 4, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$54→$62
Aug 4, 2026	Piper Sandler	Adam Maeder	PT Raise	Neutral	$55→$60
Aug 4, 2026	Evercore ISI Group	Daniel Markowitz	PT Raise	In-Line	$40→$54
Aug 4, 2026	Baird	Mike Polark	PT Raise	Neutral	$54→$59
Jul 28, 2026	UBS	Patrick Wood	Assumes	Neutral→Sell	$67→$39
Jul 16, 2026	Truist Securities	Richard Newitter	PT Raise	Hold	$50→$54
Jul 1, 2026	Freedom Capital Markets	Keith Hinton	Initiate	Buy	$62
Jun 23, 2026	Evercore ISI Group	Daniel Markowitz	Downgrade	Outperform→In-Line	$55→$40
May 7, 2026	Oppenheimer	Suraj Kalia	Maintained	Perform	—
May 5, 2026	JP Morgan	Robbie Marcus	PT Cut	Neutral	$67→$54
May 5, 2026	Piper Sandler	Adam Maeder	Downgrade	Overweight→Neutral	$85→$55
May 5, 2026	Stifel	Jonathan Block	PT Cut	Buy	$70→$65
May 5, 2026	RBC Capital	Shagun Singh	PT Cut	Sector Perform	$56→$45
May 5, 2026	Truist Securities	Richard Newitter	PT Cut	Hold	$64→$50
May 5, 2026	Evercore ISI Group	Daniel Markowitz	PT Cut	Outperform	$62→$55
May 5, 2026	Wells Fargo	Larry Biegelsen	PT Cut	Equal-Weight	$70→$56
May 5, 2026	Mizuho	Anthony Petrone	PT Cut	Outperform	$70→$55

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

JP Morgan analyst Robbie Marcus maintains Inspire Medical Systems (NYSE:INSP) with a Neutral and raises the price target from $54 to $60.

Benzinga Newsdesk

PRO
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65

Mizuho analyst Anthony Petrone maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and raises the price target from $55 to $65.

Benzinga Newsdesk

PRO
Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target

Oppenheimer analyst Suraj Kalia upgrades Inspire Medical Systems (NYSE:INSP) from Perform to Outperform and announces $85 price target.

Benzinga Newsdesk

PRO
Truist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62

Truist Securities analyst Richard Newitter reiterates Inspire Medical Systems (NYSE:INSP) with a Hold and raises the price target from $54 to $62.

Benzinga Newsdesk

PRO
Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Raises Price Target to $54

Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a In-Line and raises the price target from $40 to $54.

Benzinga Newsdesk

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

INSPI beats expectations, raises FY26 guidance. Analysts raise price targets to $59 & $60. Stock jumps 14.6% in pre-market trading. #INSP

Avi Kapoor

Inspire Medical Systems Inc

Inspire Medical Systems Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

PRO
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65

PRO
Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target

PRO
Truist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62

PRO
Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Raises Price Target to $54

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

People Also Watch

People Also Watch

Inspire Medical Systems Inc

Inspire Medical Systems Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROJP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

PROMizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65

PROOppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target

PROTruist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62

PROEvercore ISI Group Maintains In-Line on Inspire Medical Systems, Raises Price Target to $54

Inspire Medical Systems Analysts Raise Their Forecasts Following Strong Q2 Results

People Also Watch

People Also Watch

PRO
JP Morgan Maintains Neutral on Inspire Medical Systems, Raises Price Target to $60

PRO
Mizuho Maintains Outperform on Inspire Medical Systems, Raises Price Target to $65

PRO
Oppenheimer Upgrades Inspire Medical Systems to Outperform, Announces $85 Price Target

PRO
Truist Securities Reiterates Hold on Inspire Medical Systems, Raises Price Target to $62

PRO
Evercore ISI Group Maintains In-Line on Inspire Medical Systems, Raises Price Target to $54